An experience in modelling business process architecture

We present a mapping of a previously designed Business Process Architecture (BPA) meta-model onto ArchiMate, i.e., the de facto standard Enterprise Architecture (EA) modelling language. This construct mapping allows developing process maps, i.e., descriptions of (views of) the business process architecture of an organization. We demonstrate the development of these process maps using the Signavio Business Process Management (BPM) modelling platform. The developed process maps are part of the organization’s enterprise architecture model and are linked to BPMN process diagrams that detail the functional, control-flow, data and resource aspects of the business processes included in the process map. Our research contributes to the integration of BPM and EA by researching BPA as a concept common to both disciplines

An evaluation of the intuitiveness of the PGA modeling language notation

The Process-Goal Alignment (PGA) modeling method is a domain-specific modeling language that aims to achieve strategic fit of the business strategy with the internal infrastructure and processes. To ensure the acceptance and correct understanding of PGA models by business-oriented end-users, an intuitively understandable notation is of paramount importance. However, the current PGA notation was not formally tested up to now. In the paper at hand, we apply an evaluation technique for testing the intuitiveness of domain-specific modeling languages to bridge that research gap. Based on an analysis of the tasks, we propose improvements to six elements of the initial PGA notation. Our research contributes a comprehensive description of the empirical modeling language evaluation, which enables the reproducibility of the evaluation procedure by the conceptual modeling community

Gaia Data Release 2: Short-timescale variability processing and analysis

The Gaia DR2 sample of short-timescale variable candidates results from the investigation of the first 22 months of Gaia photometry for a subsample of sources at the Gaia faint end. For this exercise, we limited ourselves to the case of suspected rapid periodic variability. Our study combines fast-variability detection through variogram analysis, high-frequency search by means of least-squares periodograms, and empirical selection based on the investigation of specific sources seen through the Gaia eyes (e.g. known variables or visually identified objects with peculiar features in their light curves). The progressive definition and validation of this selection criterion also benefited from supplementary ground-based photometric monitoring of a few preliminary candidates, performed at the Flemish Mercator telescope (Canary Islands, Spain) between August and November 2017. We publish a list of 3,018 short-timescale variable candidates, spread throughout the sky, with a false-positive rate up to 10-20% in the Magellanic Clouds, and a more significant but justifiable contamination from longer-period variables between 19% and 50%, depending on the area of the sky. Although its completeness is limited to about 0.05%, this first sample of Gaia short-timescale variables recovers some very interesting known short-period variables, such as post-common envelope binaries or cataclysmic variables, and brings to light some fascinating, newly discovered variable sources. In the perspective of future Gaia data releases, several improvements of the short-timescale variability processing are considered, by enhancing the existing variogram and period-search algorithms or by classifying the identified candidates. Nonetheless, the encouraging outcome of our Gaia DR2 analysis demonstrates the power of this mission for such fast-variability studies, and opens great perspectives for this domain of astrophysics

Gaia Data Release 2: All-sky classification of high-amplitude pulsating stars

Out of the 1.69 billion sources in the Gaia Data Release 2 (DR2), more than half a million are published with photometric time series that exhibit light variations during 22 months of observation. An all-sky classification of common high-amplitude pulsators (Cepheids, long-period variables, Delta Scuti / SX Phoenicis, and RR Lyrae stars) is provided for stars with brightness variations greater than 0.1 mag in the G band. A semi-supervised classification approach was employed, firstly training multi-stage Random Forest classifiers with sources of known types in the literature, followed by a preliminary classification of the Gaia data and a second training phase that included a selection of the first classification results to improve the representation of some classes, before the application of the improved classifiers to the Gaia data. Dedicated validation classifiers were used to reduce the level of contamination in the published results. A relevant fraction of objects were not yet sufficiently sampled for reliable Fourier series decomposition, so classifiers were based on features derived from statistics of photometric time series in the G, BP, and RP bands, as well as from some astrometric parameters. The published classification results include 195,780 RR Lyrae stars, 150,757 long-period variables, 8550 Cepheids, and 8882 Delta Scuti / SX Phoenicis stars. All of these results represent candidates, whose completeness and contamination are described as a function of variability type and classification reliability. Results are expressed in terms of class labels and classification scores, which are available in the vari_classifier_result table of the Gaia archive

Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review

Background: The study objective was to assess the available data on efficacy and tolerability of antiseptics and disinfectants in treating bacterial vaginosis (BV). Methods: A systematic search was conducted by consulting PubMed (1966-2010), CINAHL (1982-2010), IPA (1970-2010), and the Cochrane CENTRAL databases. Clinical trials were searched for by the generic names of all antiseptics and disinfectants listed in the Anatomical Therapeutic Chemical (ATC) Classification System under the code D08A. Clinical trials were considered eligible if the efficacy of antiseptics and disinfectants in the treatment of BV was assessed in comparison to placebo or standard antibiotic treatment with metronidazole or clindamycin and if diagnosis of BV relied on standard criteria such as Amsel\u27s and Nugent\u27s criteria. Results: A total of 262 articles were found, of which 15 reports on clinical trials were assessed. Of these, four randomised controlled trials (RCTs) were withheld from analysis. Reasons for exclusion were primarily the lack of standard criteria to diagnose BV or to assess cure, and control treatment not involving placebo or standard antibiotic treatment. Risk of bias for the included studies was assessed with the Cochrane Collaboration\u27s tool for assessing risk of bias. Three studies showed non-inferiority of chlorhexidine and polyhexamethylene biguanide compared to metronidazole or clindamycin. One RCT found that a single vaginal douche with hydrogen peroxide was slightly, though significantly less effective than a single oral dose of metronidazole. Conclusion: The use of antiseptics and disinfectants for the treatment of BV has been poorly studied and most studies are somehow methodologically flawed. There is insufficient evidence at present to advocate the use of these agents, although some studies suggest that some antiseptics may have equal efficacy compared to clindamycin or metronidazole. Further study is warranted with special regard to the long-term efficacy and safety of antiseptics and disinfectants for vaginal use

A knowledge, attitudes, and practice survey among obstetrician-gynaecologists on intimate partner violence in Flanders, Belgium

BACKGROUND: Intimate partner violence (IPV) has consistently been found to afflict one in twenty pregnant women and is therefore considered a leading cause of physical injury, mental illness and adverse pregnancy outcome. A general antenatal screening policy has been advocated, though compliance with such guidelines tends to be low. We therefore attempted to identify potential barriers to IPV screening in a context where no guidelines have been instigated yet. METHODS: Questionnaire-based Knowledge, Attitude, and Practice survey among obstetrician-gynaecologists in Flanders, Belgium (n = 478). RESULTS: The response rate was 52.1% (249/478). Gynaecologists prove rather unfamiliar with IPV and therefore largely underestimate the extent of the problem. Merely 6.8% (17/249) of the respondents ever received or pursued any kind of education on IPV. Accordingly they do feel insufficiently skilled to deal with IPV, yet sufficiently capable of recognizing IPV among their patients. Survey participants largely refute the incentive of universal screening in favour of opportunistic screening and do not consider pregnancy as a window of opportunity for routine screening. They do consider screening for IPV as an issue of medical liability and therefore do not suffer from a lack of motivation to screen. In addition, obstetrician-gynaecologists do believe that screening for IPV may be an effective means to counteract abusive behaviours. Yet, their outcome expectancy is weighed down by their perceived lack of self-efficacy in dealing with IPV, by lack of familiarity with referral procedures and by their perceived lack of available referral services. Major external or patient-related barriers to IPV screening included a perceived lack of time and fear of offending or insulting patients. Overall, merely 8.4 % (21/245) of gynaecologists in this survey performed some kind of IPV questioning on a regular basis. Finally, physician education was found to be the strongest predictor of a positive attitude towards screening and of current screening practices. CONCLUSION: Endorsement of physician training on IPV is an important first step towards successful implementation of screening guidelines for IPV. Additional introduction of enabling and reinforcement strategies such as screening tools, patient leaflets, formal referral pathways, and physician feedback may further enhance compliance with screening recommendations and guidelines

<i>Gaia</i> Data Release 1. Summary of the astrometric, photometric, and survey properties

Context. At about 1000 days after the launch of Gaia we present the first Gaia data release, Gaia DR1, consisting of astrometry and photometry for over 1 billion sources brighter than magnitude 20.7. Aims. A summary of Gaia DR1 is presented along with illustrations of the scientific quality of the data, followed by a discussion of the limitations due to the preliminary nature of this release. Methods. The raw data collected by Gaia during the first 14 months of the mission have been processed by the Gaia Data Processing and Analysis Consortium (DPAC) and turned into an astrometric and photometric catalogue. Results. Gaia DR1 consists of three components: a primary astrometric data set which contains the positions, parallaxes, and mean proper motions for about 2 million of the brightest stars in common with the HIPPARCOS and Tycho-2 catalogues – a realisation of the Tycho-Gaia Astrometric Solution (TGAS) – and a secondary astrometric data set containing the positions for an additional 1.1 billion sources. The second component is the photometric data set, consisting of mean G-band magnitudes for all sources. The G-band light curves and the characteristics of ∼3000 Cepheid and RR-Lyrae stars, observed at high cadence around the south ecliptic pole, form the third component. For the primary astrometric data set the typical uncertainty is about 0.3 mas for the positions and parallaxes, and about 1 mas yr−1 for the proper motions. A systematic component of ∼0.3 mas should be added to the parallax uncertainties. For the subset of ∼94 000 HIPPARCOS stars in the primary data set, the proper motions are much more precise at about 0.06 mas yr−1. For the secondary astrometric data set, the typical uncertainty of the positions is ∼10 mas. The median uncertainties on the mean G-band magnitudes range from the mmag level to ∼0.03 mag over the magnitude range 5 to 20.7. Conclusions. Gaia DR1 is an important milestone ahead of the next Gaia data release, which will feature five-parameter astrometry for all sources. Extensive validation shows that Gaia DR1 represents a major advance in the mapping of the heavens and the availability of basic stellar data that underpin observational astrophysics. Nevertheless, the very preliminary nature of this first Gaia data release does lead to a number of important limitations to the data quality which should be carefully considered before drawing conclusions from the data

Maxillofacial injuries associated with intimate partner violence in women

<p>Abstract</p> <p>Background</p> <p>The facial region has been the most common site of injury following violent episodes. The purpose of this study was to determine the prevalence and pattern of maxillofacial injuries associated with intimate partner violence (IPV) in women treated at a single facility in Malaysia.</p> <p>Methods</p> <p>A retrospective review of 242 hospital records of female IPV victims who were seen at the One-Stop Crisis Centre (OSCC) in Hospital Raja Perempuan Zainab II, Kelantan over a two-year period (January 1, 2005 to December 31, 2006) was performed. A structured form was used for data collection. Information regarding the anatomical sites of injuries, types of injuries, and mechanisms of assault were obtained.</p> <p>Results</p> <p>Most victims were married (85.1%), were injured by the husband (83.5%), and had at least one previous IPV episode (85.5%). Injury to the maxillofacial region was the most common (50.4%), followed by injury to the limbs (47.9%). In 122 cases of maxillofacial injuries, the middle of the face was most frequently affected (60.6%), either alone or in combination with the upper or lower third of the face. Injury to soft tissues (contusions, abrasions and lacerations) was the most common (87.7%).</p> <p>Conclusions</p> <p>This study indicates there is a high prevalence of maxillofacial injuries associated with IPV among women treated at the OSCC in Kelantan, Malaysia.</p